Regulus Therapeutics | RGLS - Los Gastos Financieros De La Deuda



Los Gastos Financieros De La Deuda Cambio Fecha
Alnylam Pharmaceuticals USD 129.34M 84.94M 2025-12
AstraZeneca USD 484M 181M 2025-12
Biogen USD 72.6M 12.6M 2025-06
Cipla INR 140.3M 8.5M 2025-12
Compugen USD 954K 116K 2025-09
CSL USD 215M 111M 2025-12
Gilead Sciences USD 255M 1000K 2025-12
GlaxoSmithKline GBP 188M 21M 2025-12
Grifols EUR 156.07M 31.46M 2025-09
Immunic 400K 400K 2024-12
Incyte USD 582K 10K 2025-12
Intrexon USD 2K 5K 2024-06
Ionis Pharmaceuticals USD 18M 0 2025-12
Lexicon Pharmaceuticals USD 2.21M 2.74M 2024-06
Ligand Pharmaceuticals USD 910K 243K 2025-09
Merck USD 412M 85M 2025-12
Omeros USD 4.05M 5.16M 2024-09
Sangamo BioSciences 97.56M 11.39M 2025-06
Sanofi EUR -25M 99.78M 2025-12
Takeda JPY 123.63B 40.49B 2025-12